Literature DB >> 21887575

Changes in treatment of rectal cancer: increased use of low anterior resection.

A Mekras1, A Michalopoulos, V N Papadopoulos, D Mekras, V Kalles, I Tzeveleki, G Dabakis, S Netta, G Basdanis.   

Abstract

PURPOSE: The most common surgical procedures for patients with rectal cancer are low anterior resection (LAR) or abdominoperineal excision (APE). The aim of the present study is to evaluate and report the changes in the incidence of LAR and APE in the surgical treatment of rectal cancer over the last 15 years in a single surgical department.
METHODS: The patient sample consisted of 251 consecutive patients (mean age 65.17; age range 22-87) that underwent surgical treatment for rectal cancer in a single center from 1996 to 2010. This time frame was divided into three 5-year periods (1996-2000, 2001-2005 and 2006-2010). Patients were classified into one of the aforementioned groups, depending on the date of their treatment.
RESULTS: In the first period (1996-2000), 71 patients were treated for rectal cancer. Among them, 32.4% (n = 23) underwent an abdominoperineal excision (APE) while 56.3% (n = 40) were treated with LAR. In the second period (2001-2005), included 102 patients, from which 29.4% (n = 30) received an APE and 60.8% (n = 62) underwent a LAR for their disease. In the final period (2006-2010), from the 78 patients, only 12.8% (n = 10) of them underwent APE, while 74.3% (n = 58) were treated with LAR. There was a statistically significant (chi-square test, P = 0.005) difference between the 3 periods of time concerning the performance of LAR and APE.
CONCLUSIONS: According to the results of the present study, the rates of APE seem to decrease during the last 15 years, while LAR is more widely used in the surgical treatment of rectal cancer.

Entities:  

Mesh:

Year:  2011        PMID: 21887575     DOI: 10.1007/s10151-011-0731-3

Source DB:  PubMed          Journal:  Tech Coloproctol        ISSN: 1123-6337            Impact factor:   3.781


  16 in total

Review 1.  Treatment of colon and rectal cancer.

Authors:  I C Lavery; F López-Kostner; R J Pelley; R M Fine
Journal:  Surg Clin North Am       Date:  2000-04       Impact factor: 2.741

2.  Recurrence and survival after total mesorectal excision for rectal cancer.

Authors:  R J Heald; R D Ryall
Journal:  Lancet       Date:  1986-06-28       Impact factor: 79.321

3.  Use of surgical procedures and adjuvant therapy in rectal cancer treatment: a population-based study.

Authors:  A T Schroen; R D Cress
Journal:  Ann Surg       Date:  2001-11       Impact factor: 12.969

4.  A method of performing abdomino-perineal excision for carcinoma of the rectum and of the terminal portion of the pelvic colon (1908).

Authors:  W E Miles
Journal:  CA Cancer J Clin       Date:  1971 Nov-Dec       Impact factor: 508.702

5.  Impact of total mesorectal excision on the results of surgery of distal rectal cancer.

Authors:  W L Law; K W Chu
Journal:  Br J Surg       Date:  2001-12       Impact factor: 6.939

6.  Rectal cancer: the Basingstoke experience of total mesorectal excision, 1978-1997.

Authors:  R J Heald; B J Moran; R D Ryall; R Sexton; J K MacFarlane
Journal:  Arch Surg       Date:  1998-08

7.  Total mesorectal excision in the operative treatment of carcinoma of the rectum.

Authors:  W E Enker; H T Thaler; M L Cranor; T Polyak
Journal:  J Am Coll Surg       Date:  1995-10       Impact factor: 6.113

8.  Treatment of rectal cancer by low anterior resection with coloanal anastomosis.

Authors:  P B Paty; W E Enker; A M Cohen; G Y Lauwers
Journal:  Ann Surg       Date:  1994-04       Impact factor: 12.969

9.  Total mesenteric excision in the surgical treatment of rectal cancer: a prospective study.

Authors:  R B Arenas; A Fichera; D Mhoon; F Michelassi
Journal:  Arch Surg       Date:  1998-06

10.  The mesorectum in rectal cancer surgery--the clue to pelvic recurrence?

Authors:  R J Heald; E M Husband; R D Ryall
Journal:  Br J Surg       Date:  1982-10       Impact factor: 6.939

View more
  2 in total

Review 1.  Evolving treatment strategies for colorectal cancer: a critical review of current therapeutic options.

Authors:  Daniel C Damin; Anderson R Lazzaron
Journal:  World J Gastroenterol       Date:  2014-01-28       Impact factor: 5.742

2.  Endoluminal negative-pressure therapy for preventing rectal anastomotic leaks: a pilot study in a pig model.

Authors:  Amber L Shada; Laura H Rosenberger; Mark J Mentrikoski; Michael A Silva; Sanford H Feldman; Daniel E Kleiner
Journal:  Surg Infect (Larchmt)       Date:  2014-01-29       Impact factor: 2.150

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.